Terkko Navigator / Journal of Neurology, Neurosurgery and Psychiatry

Guillain-Barre syndrome: looking back... and forward

Original research: Second IVIg course in Guillain-Barre syndrome with poor prognosis: the non-randomised ISID study

Is the future of symptomatic intracranial atherosclerotic stenosis management promising?

In vivo tracking of TDP43 in ALS: cognition as a new biomarker for brain pathology

Genetic variants in incident SUDEP cases from a community-based prospective cohort with epilepsy

Peripheral blood helper T cell profiles and their clinical relevance in MOG-IgG-associated and AQP4-IgG-associated disorders and MS

Multifocal motor neuropathy: controversies and priorities

Executive, language and fluency dysfunction are markers of localised TDP-43 cerebral pathology in non-demented ALS

Association between midlife dementia risk factors and longitudinal brain atrophy: the PREVENT-Dementia study

Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice

Pure tone audiometry and cerebral pathology in healthy older adults

Pain and the immune system: emerging concepts of IgG-mediated autoimmune pain and immunotherapies

Long-term deep brain stimulation of the ventral anterior limb of the internal capsule for treatment-resistant depression

Structural network changes in cerebral small vessel disease

Intensive Statin Treatment in Acute Ischaemic Stroke Patients with Intracranial Atherosclerosis: a High-Resolution Magnetic Resonance Imaging study (STAMINA-MRI Study)

Abnormal coagulation parameters are a common non-neuromuscular feature in patients with spinal muscular atrophy

Plasma pNfH levels differentiate SBMA from ALS

Cerebellum is more concerned about visceral than somatic pain

Retinitis pigmentosa prior to familial ALS caused by a homozygous cilia and flagella-associated protein 410 mutation

Familial flail leg ALS caused by PFN1 mutation

Jewels in the crown: a century of achievement for the Journal of Neurology, Neurosurgery & Psychiatry

Multiple system atrophy: the nature of the beast revisited

Using clinically stable disease (NEDA 2) as a proxy for disease impact and employment in MS paints an incomplete picture

Keeping people with MS in the workforce through effective treatment

Stay at home with the amyotrophic lateral sclerosis functional rating scale

FGFR3 autoantibodies in sensory neuronopathy

Case for a new corticosteroid treatment trial in optic neuritis: review of updated evidence

Psychosis and longitudinal outcomes in Huntington disease: the COHORT Study

Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: a systematic review and meta-analysis of randomised controlled trials

Effect modification of the association between total cigarette smoking and ALS risk by intensity, duration and time-since-quitting: Euro-MOTOR

CSF and blood Kallikrein-8: a promising early biomarker for Alzheimers disease

Clinical characterisation of sensory neuropathy with anti-FGFR3 autoantibodies

Consistent control of disease activity with fingolimod versus IFN {beta}-1a in paediatric-onset multiple sclerosis: further insights from PARADIGMS

Clinically stable disease is associated with a lower risk of both income loss and disability pension for patients with multiple sclerosis

Development and assessment of the inter-rater and intra-rater reproducibility of a self-administration version of the ALSFRS-R

Haematoma evacuation in cerebellar intracerebral haemorrhage: systematic review

Disentangling the multiple links between renal dysfunction and cerebrovascular disease

Midbrain MRI assessments in progressive supranuclear palsy subtypes

Burden of brain disorders in Europe in 2017 and comparison with other non-communicable disease groups

Longitudinal (18F)AV-1451 PET imaging in a patient with frontotemporal dementia due to a Q351R MAPT mutation

CSF tau proteins correlate with an atypical clinical presentation in dementia with Lewy bodies

12.15 Distinguishing neurosarcoidosis from multiple sclerosis based on cerebrospinal fluid analysis: a retrospective cohort study

11.15 MS incidence rates vary threefold by health board in scotland, persistently

11.27 Late onset multiple sclerosis in north wales

11.51 Stiff person and related syndromes: review of 21 patients and their response to treatment

11.15 ABN survey 2016: geographic variations in service provision

11.27 Understanding variability in UK acute neurology services: what works, and what doesnt?

11.39 Association of british neurologists sustainability special interest group (ABN sustainability SIG): formation, objectives and invitation

11.51 Introducing atraumatic needles to the neurology ambulatory day case unit - a quality improvement project

12.03 Acute neurology: a two week snapshot in a district general hospital